Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP733884.RA-odlQ9IiLJ6MTsqASX1SykVAP_K56bgxtcxwCI_PJkk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP733884.RA-odlQ9IiLJ6MTsqASX1SykVAP_K56bgxtcxwCI_PJkk130_assertion type Assertion NP733884.RA-odlQ9IiLJ6MTsqASX1SykVAP_K56bgxtcxwCI_PJkk130_head.
- NP733884.RA-odlQ9IiLJ6MTsqASX1SykVAP_K56bgxtcxwCI_PJkk130_assertion description "[Understanding genetic lesions that occur in MTC is a prerequisite to identifying molecular therapeutic targets in MTC and in improving the efficacy of RET-targeted therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP733884.RA-odlQ9IiLJ6MTsqASX1SykVAP_K56bgxtcxwCI_PJkk130_provenance.
- NP733884.RA-odlQ9IiLJ6MTsqASX1SykVAP_K56bgxtcxwCI_PJkk130_assertion evidence source_evidence_literature NP733884.RA-odlQ9IiLJ6MTsqASX1SykVAP_K56bgxtcxwCI_PJkk130_provenance.
- NP733884.RA-odlQ9IiLJ6MTsqASX1SykVAP_K56bgxtcxwCI_PJkk130_assertion SIO_000772 19383830 NP733884.RA-odlQ9IiLJ6MTsqASX1SykVAP_K56bgxtcxwCI_PJkk130_provenance.
- NP733884.RA-odlQ9IiLJ6MTsqASX1SykVAP_K56bgxtcxwCI_PJkk130_assertion wasDerivedFrom befree-2016 NP733884.RA-odlQ9IiLJ6MTsqASX1SykVAP_K56bgxtcxwCI_PJkk130_provenance.
- NP733884.RA-odlQ9IiLJ6MTsqASX1SykVAP_K56bgxtcxwCI_PJkk130_assertion wasGeneratedBy ECO_0000203 NP733884.RA-odlQ9IiLJ6MTsqASX1SykVAP_K56bgxtcxwCI_PJkk130_provenance.